Standard

Pathomorphosis of anxiety disorder in patients with intestinal dysbiosis. / Uspenskiǐ, I. P.; Balukova, E. V.

In: Ėksperimental'naia i klinicheskaia gastroėnterologiia = Experimental & clinical gastroenterology, No. 7, 2009, p. 91-96.

Research output: Contribution to journal › Review article › peer-review

Harvard

Uspenskiǐ, IP & Balukova, EV 2009, 'Pathomorphosis of anxiety disorder in patients with intestinal dysbiosis', Ėksperimental'naia i klinicheskaia gastroėnterologiia = Experimental & clinical gastroenterology, no. 7, pp. 91-96.

APA

Uspenskiǐ, I. P., & Balukova, E. V. (2009). Pathomorphosis of anxiety disorder in patients with intestinal dysbiosis. Ėksperimental'naia i klinicheskaia gastroėnterologiia = Experimental & clinical gastroenterology, (7), 91-96.

Vancouver

Uspenskiǐ IP, Balukova EV. Pathomorphosis of anxiety disorder in patients with intestinal dysbiosis. Ėksperimental'naia i klinicheskaia gastroėnterologiia = Experimental & clinical gastroenterology. 2009;(7):91-96.

Author

Uspenskiǐ, I. P. ; Balukova, E. V. / Pathomorphosis of anxiety disorder in patients with intestinal dysbiosis. In: Ėksperimental'naia i klinicheskaia gastroėnterologiia = Experimental & clinical gastroenterology. 2009 ; No. 7. pp. 91-96.

BibTeX

@article{2e234c5d4d3e4589a176b254b74ca1d4,
title = "Pathomorphosis of anxiety disorder in patients with intestinal dysbiosis",
abstract = "It is known, that anxiety is one of the most wide-spread mental disorders in-between psychiatric state and it takes part in pathogenesis a lot of somatic diseases as well. At the same time the host bowel microbiota participates in metabolic control of vital human functions such as mood and behavioural reactions. This title connection reveals some new therapeutic opportunity in treatment of psychiatric disorders that based on using with probiotics. In case non-clinically significant anxiety it is claimed to use probiotic (Enterol) however in case clinically significant anxiety it is claimed to use non-benzodiazepine tranquilizer (Stresam).",
author = "Uspenskiǐ, {I. P.} and Balukova, {E. V.}",
year = "2009",
language = "русский",
pages = "91--96",
journal = "Experimental and Clinical Gastroenterology",
issn = "1682-8658",
publisher = "Глобал медиа технологии",
number = "7",

}

RIS

TY - JOUR

T1 - Pathomorphosis of anxiety disorder in patients with intestinal dysbiosis

AU - Uspenskiǐ, I. P.

AU - Balukova, E. V.

PY - 2009

Y1 - 2009

N2 - It is known, that anxiety is one of the most wide-spread mental disorders in-between psychiatric state and it takes part in pathogenesis a lot of somatic diseases as well. At the same time the host bowel microbiota participates in metabolic control of vital human functions such as mood and behavioural reactions. This title connection reveals some new therapeutic opportunity in treatment of psychiatric disorders that based on using with probiotics. In case non-clinically significant anxiety it is claimed to use probiotic (Enterol) however in case clinically significant anxiety it is claimed to use non-benzodiazepine tranquilizer (Stresam).

AB - It is known, that anxiety is one of the most wide-spread mental disorders in-between psychiatric state and it takes part in pathogenesis a lot of somatic diseases as well. At the same time the host bowel microbiota participates in metabolic control of vital human functions such as mood and behavioural reactions. This title connection reveals some new therapeutic opportunity in treatment of psychiatric disorders that based on using with probiotics. In case non-clinically significant anxiety it is claimed to use probiotic (Enterol) however in case clinically significant anxiety it is claimed to use non-benzodiazepine tranquilizer (Stresam).

UR - http://www.scopus.com/inward/record.url?scp=77953308321&partnerID=8YFLogxK

M3 - Обзорная статья

C2 - 20469713

AN - SCOPUS:77953308321

SP - 91

EP - 96

JO - Experimental and Clinical Gastroenterology

JF - Experimental and Clinical Gastroenterology

SN - 1682-8658

IS - 7

ER -

ID: 89334828